The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Subgroup analyses results of the PETACC8 phase III trial comparing adjuvant FOLFOX4 with or without cetuximab (CTX) in resected stage III colon cancer (CC).
Julien Taïeb
Consultant or Advisory Role - Merck KGaA; Roche/Genentech; Sanofi
Honoraria - Amgen; Merck KGaA; Roche/Genentech; Sanofi
Josep Tabernero
Consultant or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; ImClone Systems; Lilly; Merck KGaA
Honoraria - Amgen; Merck KGaA; Novartis; Roche; Sanofi
Enrico Mini
No relevant relationships to disclose
Fabien Subtil
No relevant relationships to disclose
Gunnar Folprecht
Consultant or Advisory Role - Bayer; Bristol-Myers Squibb; Merck KGaA; Roche/Genentech; Sanofi
Honoraria - Amgen; Bristol-Myers Squibb; Merck KGaA; Novartis; Roche/Genentech; Sanofi
Research Funding - Merck KGaA; Pfizer; Sanofi
Jean-Luc Van Laethem
No relevant relationships to disclose
Joseph Thaler
Honoraria - Merck Serono; Sanofi
Research Funding - Merck Serono
John A. Bridgewater
Consultant or Advisory Role - Roche
Honoraria - Merck
Evaristo Sanches
No relevant relationships to disclose
Lone Petersen
No relevant relationships to disclose
Laurence Collette
No relevant relationships to disclose
Eric Van Cutsem
Research Funding - Merck Serono
Karine Le Malicot
No relevant relationships to disclose
Philippe Rougier
Honoraria - Merck; Sanofi
Ramon Salazar
No relevant relationships to disclose
Laurent Bedenne
Honoraria - Amgen
Research Funding - Chugai Pharma; Pfizer
Jean Francois Emile
No relevant relationships to disclose
Pierre Laurent-Puig
Honoraria - Merck Serono
Come Lepage
No relevant relationships to disclose